The role of radiotherapy in the treatment of oral cavity cancer

Abstract

Radiotherapy plays a critical role in the treatment of oral cavity squamous cell carcinoma as monotherapy in early stage cancer or combined with surgery and/or chemotherapy in advances ones. Recent developments in the imaging of cancer and radiation technology have allowed developing more precise delivery of treatment with recent data demonstrating improvement in survival and lessening of adverse toxics effects of radiation. This review will focus in the recent advances and current state-of-the-art in radiation oncology both external beam radiotherapy and brachytherapy. As complexity of cancer treatments increases a close coordination between head-neck surgeons and radiation oncologist is needed due to a significant proportion of patients will be treated with combined modality therapy.

Keywords

Radiotherapy / intensity modulated radiation therapy / high dose rate / low dose rate / head neck cancer / brachytherapy

References

[1] National Comprehensive Cancer Network. Fort Washington PA. c2015. NCCN Practice Guidelines in Oncology: Head and Neck Cancers, version 1. 2015 [updated 2015 Dec 05; cited 2016 Feb 22] Available from http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf

[2] Unger K,Chen A.Lee NY.Oral Cavity Cancer..Target Volume Delineation and Field Setup. A Practical Guide for Conformal and Intensity-Modulated Radiation Therapy.2013;Berlin-HeidelbergSpringer-Verlag35-44

[3] Grégoire V,Budach W,Hamoir M,Lee A,MaingonP,O'Sullivan B,Lengele B.Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines..Radiother Oncol2014;110:172-81

[4] Liu SH,Leu YS,Liu CJ,Chang YF,Tsai JT.Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy for oral cavity cancer..Head Neck2015;37:933-9

[5] Leclerc M,Lacornerie T,Kramar A.Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy..Radiother Oncol2015;116:87-93

[6] Brouwer CL,Bourhis J,Grau C,van Herk M,Maingon P,O'Sullivan B,Rosenthal DI,Langendijk JA.CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines..Radiother Oncol2015;117:83-90

[7] Chao KSC,Marinetti TD.Halperin EC,Perez CA.Intensity-Modulated Radiation Treatment Techniques and Clinical Applications..Perez and Brady's Principles and Practice of Radiation Oncology. 6th ed.2013;PhiladelphiaLippincott Williams and Wilkins221-45

[8] Orlandi E,Pignoli E,Giostra A.Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) intensity modulated radiotherapy (IMRT) for head and neck cancer: a review..Crit Rev Oncol Hematol2010;73:111-25

[9] Marta GN,de Andrade Carvalho H,Hanna SA,da Silva JL,Vita Abreu CE.Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis..Radiother Oncol2014;110:9-15

[10] Beadle BM,Elting LS,Ang KK,Guadagnolo BA.Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis..Cancer2014;120:702-10

[11] Mazeron JJ,Haie-Méder C,Levendag P,Polo A,Strnad V.GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas..Radiother Oncol2009;91:150-6

[12] Lau HY,Flores AD.Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio..Radiother Oncol1996;39:15-8

[13] Liu Z,Zhang D.High dose rate versus low dose rate brachytherapy for oral cancer--a meta-analysis of clinical trials..PLoS One2013;8:e65423 PMCID:PMC3677879

[14] Nag S,Demanes DJ,Vikram B.The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma..Int J Radiat Oncol Biol Phys2001;50:1190-8

[15] Petera J,Paluska P,Macingova Z,Frgala T,Vosmik M.High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma - a radiobiological study..Neoplasma2009;56:163-8

[16] Yamazaki H,Yoshida K,Furukawa S,Shimizutani K.Brachytherapy for early oral tongue cancer: low dose rate to high dose rate..J Radiat Res2003;44:37-40

[17] Van Limbergen E, Joiner M, Van der Kogel A, Dörr W. Radiobiology of LDR, HDR, PDR and VLDR Brachytherapy. In: Van Limbergen E, Pötter R, Hoskin P, Baltas D, editors. The GEC ESTRO Handbook of Brachytherapy. 2nd ed (ebook version 1 12/11/2015). Available from: http://www.estro.org/search?type=Activities&q=radiobiology+ldr+hdr&alloptions=on

[18] Grégoire V,Cosnard G,Reychler H.Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience..Radiother Oncol2000;56:135-50

[19] Huang SH,Lockwood G,O'Sullivan B.Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: A meta-analysis of reported studies..Cancer2009;15:1489-97

[20] Sresty NV,Raju AK,Sudarshan G.Acquisition of equal or better planning results with interstitial brachytherapy when compared with intensity-modulated radiotherapy in tongue cancers..Brachytherapy2010;9:235-8

[21] Studer G,Bredell M,Huber G,Najafi Y,Rordorf T,Glanzmann C.Follow up after IMRT in oral cavity cancer: update..Radiat Oncol2012;7:84 PMCID:PMC3488022

[22] Leung TW,Kwan KH,Wong CM,Leung LC.High dose rate brachytherapy for early stage oral tongue cancer..Head Neck2002;24:274-81

[23] Martínez-Monge R,Cambeiro M,Montesdeoca N,Alcalde J.Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer..Brachytherapy2009;8:26-33

[24] Guinot JL,Tortajada MI,Estellés E,Muelas R,Mengual JL.Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma..Brachytherapy2010;9:227-34

[25] Oota S,Yoshimura R,Miura M.Brachytherapy of stage II mobile tongue carcinoma. Prediction of local control and QOL..Radiat Oncol2006;1:21 PMCID:PMC1543646

[26] Fujita M,Kashiwado K,Kashimoto K,Matsuura K.Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications..Int J Radiat Oncol Biol Phys1999;44:767-75

[27] Bachaud JM,Allouache N,Alzieu C,Serrano E.Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth..Radiother Oncol1994;31:199-206

[28] Inoue T,Yoshida K,Shimamoto S,Yamazaki H,Teshima T.Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer..Int J Radiat Oncol Biol Phys2001;51:171-5

[29] Yamazaki H,Yoshida K,Furukawa S,Shimizutani K.Brachytherapy for early oral tongue cancer: low dose rate to high dose rate..J Radiat Res2003;44:37-40

[30] Yamazaki H,Yoshida K,Furukawa S,Shimizutani K.Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1-T3 oral tongue cancer: influence of age on outcome..Anticancer Res2007;27:491-7

[31] Ihara N,Yoshimura R,Miura M.Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue..Acta Oncol2005;44:709-16

[32] Kakimoto N,Inoue T,Furukawa S,Yoshioka Y,Tanaka E.Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer..Radiother Oncol2003;68:123-8

[33] Akiyama H,Shimizutani K,Koizumi M,Kakimoto N,Furukawa S.Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer..J Radiat Res2012;53:722-6 PMCID:PMC3430427

[34] Donath D,Shenouda G,Tabah R.The potential uses of high-dose-rate brachytherapy in patients with head and neck cancer..Eur Arch Otorhinolaryngol1995;252:321-4

[35] Inoue T,Yamazaki H,Kagawa K,Shiomi H,Shimizutani K,Nose T,Furukawa S.High dose rate versus LDR interstitial radiotherapy for carcinoma of the floor of mouth..Int J Radiat Oncol Biol Phys1998;41:53-8

[36] Matsumoto K,Shioyama Y,Atsumi K,Ooga S,Uehara S,Honda H.Treatment outcome of high-dose-rate interstitial radiation therapy for patients with stage I and II mobile tongue cancer..Jpn J Clin Oncol2013;43:1012-7

[37] Khalilur R,Shibuya H.Brachytherapy for tongue cancer in the very elderly is an alternative to external beam radiation..Br J Radiol2011;84:747-9 PMCID:PMC3473442

[38] Vedasoundaram P,Ks R,Sinnatamby M,Kandasamy S.Role of high dose rate interstitial brachytherapy in early and locally advanced squamous cell carcinoma of buccal mucosa..Springerplus2014;3:590 PMCID:PMC4197196

[39] Lee SU,Moon SH,Park JY,Lee SH,Jeong CY.Clinical outcome of high-dose-rate interstitial brachytherapy in patients with oral cavity cancer..Radiat Oncol J2014;32:238-46 PMCID:PMC4282998

[40] Tuček L,Sirák I,Doležalová H,Hodek M,Paluska P.Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer..Rep Pract Oncol Radiother2011;16:243-7 PMCID:PMC3863239

[41] Pernot M,Peiffert D,Lapeyre M,Luporsi E,Nancy VL.Role of interstitial brachytherapy in oral and oropharyngeal carcinoma: reflection of a series of 1344 patients treated at the time of initial presentation..Otholaryngol Head Neck Surg1996;115:519-26

[42] Lefebvre JL,Buisset E,Van JT.Management of early oral cavity cancer. Experience of Centre Oscar Lambret..Eur J Cancer B Oral Oncol1994;30B:216-20

[43] Mazeron JJ,Le Péchoux C,Grimard L,Le Bourgeois JP.Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192..Radiother Oncol1991;21:39-47

[44] Marsiglia H,Sasso G,Gerbaulet A.Brachytherapy for T1-T2 floor of mouth cancers: the Gustave-Roussy Institute experience..Int J Radiat Oncol Biol Phys2002;52:1257-63

[45] Dearnaley DP,A'Hearn RP.Interstitial irradiation for carcinoma of the tongue and floor of mouth: royal marsden hospital experience 1970-1986..Radiother Oncol1991;21:183-92

[46] Fujita M,Kashiwado K,Kashimoto K,Matsuura K.Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications..Int J Radiat Oncol Biol Phys1999;44:767-75

[47] Ihara N,Yoshimura R,Miura M.Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue..Acta Oncol2005;44:709-16

[48] Bourhis J,Audry H,Saunders M,Horiot JC,Pajak TF,O'Sullivan B,Hliniak A,Hay JH,Fallai C,Sylvester R.Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis..Lancet2006;368:843-54

[49] Glenny AM,Worthington HV,Oliver R,Macluskey M,Chan KK,CSROC Expert Panel..Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy..Cochrane Database Syst Rev2010;(12):CD006387

[50] Pignon JP,Maillard E.Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients..Radiother Oncol2009;92:4-14

[51] Blanchard P,Holostenco V,Baey C,Pignon JP.Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site..Radiother Oncol2011;100:33-40

[52] Bourhis J,Graff P,Maingon P,Gery B,Alfonsi M,Pignon T,Rives M,Daly-Schveitzer N,Tuchais C,Guerif S,Favrel V,Lusinchi A,Pinna A,Blanchard P.Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial..Lancet Oncol2012;13:145-53

[53] Nguyen-Tan PF,Ang KK,Rosenthal DI,Kim H,Raben A,Fortin A,Westra WH,Jordan RC,List M.Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity..J Clin Oncol2014;32:3858-66 PMCID:PMC4239304

[54] Martinez-Useros J.The challenge of blocking a wider family members of EGFR against head and neck squamous cell carcinomas..Oral Oncol2015;51:423-30

[55] Bonner JA,Giralt J,Jones CU,Raben D,Spencer SA,Youssoufian H,Ang KK.Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival..Lancet Oncol2010;11:21-8

[56] Fletcher GH.Radiotherapeutic management of surgical recurrences and postoperative residuals tumors of the head and neck..Radiology1970;95:185-8

[57] Marcus RBJr,Cassissi NJ.Postoperative irradiation for squamous cell carcinomas of the head and neck: analysis of time-dose factors related to control above the clavicles..Int J Radiat Oncol Biol Phys1979;5:1943-49

[58] Lundahl RE,Bonner JA,Lewis JE,McCaffrey TV.Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis..Int J Radiat Oncol Biol Phys1998;40:529-34

[59] Lavaf A,Cesaretti JA,Kao J.Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma..Cancer2008;112:535-43

[60] Kao J,Teng MS,Genden EM.Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage..Int J Radiat Oncol Biol Phys2008;71:362-70

[61] Hu KS,Harrison LB.Harrison LB,Hong WK.Management of the neck: radiation therapy and chemotherapy..Head and Neck Cancer. A Multidisciplinary Approach. 3rd ed.2009;PhiladelphiaLippincot-Williams & Wilkins204-31

[62] Moergel M,Ingel K,Al-Nawas B.Effectiveness of Postoperative Radiotherapy in Patients with Small Oral and Oropharyngeal Squamous Cell Carcinoma and Concomitant Ipsilateral Singular Cervical Lymph Node Metastasis (pN1)..Strahlenther Onkol2011;187:337-43

[63] Shrime MG,Dawson L,Gilbert RW,Brown DH.The impact of adjuvant radiotherapy on survival in T1-2N1 squamous cell carcinoma of the oral cavity..Arch Otolaryngol Head Neck Surg2010;136:225-8

[64] Leemans CR,Nauta JJ,Snow GB.Regional Lymph node involvement and its signficance in the development of distan metastases in head and neck carcinoma..Cancer1993;71:452-6

[65] Cooper JS,Forastiere A,Fu KK,Laramore GE.Precisely defining high-risk operable head and neck tumors based on RTOG #83-03 and #88-24: Targets for postoperative radiochemotherapy?.Head Neck1998;20:588-94

[66] Langendijk JA,van der Waal I,Berkof J.Risk group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy..Cancer2005;104:1408-17

[67] Jonkman A,Terhaard CH,van den Ende PL,Verhoef LC,Leemans CR.Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postperative radiotherapy..Int J Radiat Oncol Biol Phys2007;68:119-25

[68] Expert Panel on Radiation Oncology-Head and Neck,Saba N,Garg MK,McDonald MW,Smith RV,Yom SS.ACR appropriateness criteria^® adjuvant therapy for resected squamous cell carcinoma of the head and neck..Oral Oncol2011;47:554-9

[69] Bur AM,Weinstein GS.Adjuvant radiotherapy for early head and neck squamous cell carcinoma with perineural invasion: a systematic review..Head Neck2016;38 Suppl 1:E2350-7

[70] Huang J,Brouwers M,Mackillop WJ.Does delay instarting treatment affect the outcomes of radiotherapy? a systematic review..J Clin Oncol2003;21:555-63

[71] Chen Z,Pearcey R,Mackillop WJ.The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature..Radiother Oncol2008;87:3-16

[72] van Harten MC,Kross KW,van den Brekel MW.Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival..Oral Oncol2015;51:272-8

[73] Peters LJ.Applying radiobiological principles to combined modality treatment of head and neck cancer - the time factor..Int J RadiatOncol Biol Phys1997;39:831-6

[74] González Ferreira JA,Azinovic I.Effect of radiotherapy delay in overall treatment time on local control andsurvival in head and neck cancer: review of the literature..Rep Pract Oncol Radiother2015;20:328-39 PMCID:PMC4597087

[75] Ang KK,Brown BW,Foote RL,Geara FB,Goepfert H.Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer..Int J Radiat Oncol Biol Phys2001;51:571-8

[76] Langendijk JA,Leemans CR,Smeele LE,Slotman BJ.Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time..Int J Radiat Oncol Biol Phys2003;57:693-700

[77] Peters LJ,Ang KK,Maor MH,Morrison WH,Garden AS,Oswald MJ.Evaluation of the dose for postoperative radioation therapy of head and neck cancer: first report of a prospective randomized trial..Int J Radiat Oncol Biol Phys1993;26:3-11

[78] Winquist E,Gilbert R.Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis..Head Neck2007;29:38-46

[79] Bernier J,Pajak TF,Bourhis J,Ozsahin EM,Jassem J,Lefèbvre JL.Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of EORTC (#22931) and RTOG (#9501)..Head Neck2005;27:843-50

[80] Cooper JS,Forastiere AA,Campbell BH,Kish JA,Cmelak AJ,Machtay M,Chao KS,Lee N.PostpeRative concurrent radiotherapy and chemotherapy for high risk squamous cell carcinoma of the head and neck..N Engl J Med2004;350:1937-44

[81] Bernier J,Ozsahin M,Lefèbvre JL,Giralt J,Rolland F,Cognetti F,Kirkpatrick A,European Organization for Research and Treatment of Cancer Trial 22931..Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer..N Engl J Med2004;350:1945-52

[82] Cooper JS,Pajak TF,Jacobs J,Kish JA,Cmelak AJ,Lustig R,Thorstad W,Yom SS.Long-term follow-up of the RTOG 9501/Intergroup Phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck..Int J Radiat Oncol Biol Phys2012;84:1198-205 PMCID:PMC3465463

[83] Eisbruch A.Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer..Semin Radiat Oncol2009;19:43-52 PMCID:PMC3734795

[84] Chen AM,Luu Q,Vijayakumar S.Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer..Int J Radiat Oncol Biol Phys2011;80:1423-9

[85] Grégoire V,Hamoir M.Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck..Radiother Oncol2006;79:15-20

[86] Liu SH,Leu YS,Liu CJ,Chang YF,Tsai JT.Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy for oral cavity cancer..Head Neck2015;37:933-9

[87] Merlotti A,Vigna-Taglianti R,Lastrucci L,Gambaro G,Miccichè F,Pergolizzi S,Corvò R,Sanguineti G.Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group..Radiat Oncol2014;9:264 PMCID:PMC4316652

[88] Ko HC,Mourad WF,Harrison LB,Bakst RL.A contouring guide for head and neck cancers with perineural invasion..Pract Radiat Oncol2014;4:e247-58

[89] Goineau A,Malard O,Lisbona A,Delamazure AS,Bardet E.Postoperative interstitial brachytherapy for resectable squamous cell carcinoma of the tongue..Brachytherapy2015;14:71-6

[90] Petera J,Laco J,Tuček L.High-dose-rate brachytherapy in early oral cancer with close or positive margins..Brachytherapy2015;14:77-83

[91] Lapeyre M,Racadot S,Kaminsky MC,Dolivet G,Luporsi E.Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins..Head Neck2004;26:216-23

[92] Pernot M,Carolus JM,Hoffstetter S,Peiffert D,Luporsi E,Noël A.Indications, techniques and results of postoperative brachytherapy in cancer of the oral cavity..Radiother Oncol1995;35:186-92

[93] Fietkau R,Iro H,Farmand M,Sauer R.Interstitial and percutaneous radiotherapy after limited surgery in carcinoma of the oral cavity..Strahlenther Onkol1991;167:591-8

[94] Chan AK,Le LW,Dawson LA,Cho BC,Ringash J,Chan K,O'Sullivan B,Hope AJ.Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure..Oral Oncol2013;49:255-60

[95] Hoffmann M,Zwicker F,Schwahofer A,Huber PE.Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity..Radiat Oncol2015;10:251 PMCID:PMC4670508

[96] Sher DJ,Balboni TA,Haddad RI,Lorch J,Annino DJ.Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy..Int J Radiat Oncol Biol Phys2011;81:e215-22

[97] Gomez DR,Gomez J,Wu AJ,Pfister DG,Shah JP,Wong RJ.Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers..Int J Radiat Oncol Biol Phys2009;73:1096-103

[98] Chakraborty S,Babu S,Thiagarajan SK.Locoregional recurrences after post-operative volumetric modulated arc radiotherapy (VMAT) in oral cavity cancers in a resource constrained setting: experience and lessons learned..Br J Radiol2015;88:20140795 PMCID:PMC4651253

[99] Studer G,Bredell M,Huber G,Najafi Y,Rordorf T,Glanzmann C.Follow up after IMRT in oral cavity cancer: update..Radiat Oncol2012;7:84 PMCID:PMC3488022

[100] Collan J,Vaalavirta L,Kajanti M,Tenhunen M.Patterns of relapse following surgery and postoperative intensity modulated radiotherapy for oral and oropharyngeal cancer..Acta Oncol2011;50:1119-25

[101] Geretschläger A,Crowe S,Manser P,Aebersold DM.Outcome and patterns of failure after postoperative intensity modulated radiotherapy for locally advanced or high-risk oral cavity squamous cell carcinoma..Radiat Oncol2012;7:175 PMCID:PMC3551735

[102] Yao M,Funk GF,Tan H,Dornfeld KJ.The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the university of iowa experience..Int J Radiat Oncol Biol Phys2007;67:1332-41

[103] Daly ME,Kozak MM,Murphy JD,Loo BWJr,Fischbein NJ.Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control..Int J Radiat Oncol Biol Phys2011;80:1412-22